Kevin Feeley

CHIEF FINANCIAL OFFICER

Kevin Feeley (CHIEF FINANCIAL OFFICER) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in GeneDx Holdings Corp. (WGS). The largest single filing was $526K of WGS (4,867 sh across 2 lots, as filed), executed Sep 30 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 10 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.9M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $82.7M across their filed names

Open performance→

Volume by month

Buys $0 Sells $12.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 10 filings

Sector per market data · by filing · past 12 months

Most traded names

WGS

GeneDx Holdings Corp. WGS · 0 buys · 21 sells 21 filings

Recent filings

WGSSALE GeneDx Holdings Corp. View filing → $251K
2,549 sh across 2 lots
Exec Sep 16
Filed Sep 18 · 4:39 PM ET WGSSALE GeneDx Holdings Corp. View filing → $108K
1,285 sh × $84.22
Exec Sep 9
Filed Sep 11 · 4:10 PM ET WGSSALE GeneDx Holdings Corp. View filing → $128K
2,106 sh × $60.83
Exec Jun 16
Filed Jun 18 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $433K
6,862 sh across 3 lots
Exec Mar 26
Filed Mar 30 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $418K
5,449 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $111K
1,280 sh × $86.75
Exec Mar 9
Filed Mar 11 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $486K
6,187 sh across 3 lots
Exec Mar 4
Filed Mar 5 · 5:30 PM ET WGSSALE GeneDx Holdings Corp. View filing → $237K
1,650 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET More filings →